StonvexLoading…
StonvexCore line items from WIMI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $60.07M | $75.39M | $82.65M | $97.97M |
Operating Income | $-5.50M | $-4.04M | $-87.12M | $-44.33M |
Net Income | $44.00M | $9.97M | $-59.47M | $-51.36M |
EPS (Diluted) | $2.27 | $1.01 | $-0.34 | $-0.30 |
Total Assets | $513.35M | $299.42M | $145.57M | $180.96M |
Total Liabilities | $134.28M | $106.76M | $38.05M | $15.93M |
Cash & Equivalents | $186.94M | $148.92M | $47.75M | $82.24M |
Free Cash Flow OCF − CapEx | $8.39M | $74.13M | $2.89M | $-34.35M |
Shares Outstanding | 19.42M | 9.82M | 176.30M | 153.30M |